Literature DB >> 17936760

Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver.

Hiroyuki Oku1, Fumihiko Matsuura, Masahiro Koseki, Jose C Sandoval, Miyako Yuasa-Kawase, Kazumi Tsubakio-Yamamoto, Daisaku Masuda, Norikazu Maeda, Tohru Ohama, Masato Ishigami, Makoto Nishida, Ken-ichi Hirano, Shinji Kihara, Masatsugu Hori, Iichiro Shimomura, Shizuya Yamashita.   

Abstract

Plasma high density lipoprotein (HDL)-cholesterol levels are inversely correlated with the incidence of cardiovascular diseases. HDL is mainly assembled in the liver through the ATP-binding cassette transporter (ABCA1) pathway. In humans, plasma HDL-cholesterol levels are positively correlated with plasma adiponectin (APN) concentrations. Recently, we reported that APN enhanced apolipoprotein A-I (apoA-I) secretion and ABCA1 expression in HepG2 cells. In the present study, we investigated HDL assembly in APN-knockout (KO) mice. The apoA-I protein levels in plasma and liver were reduced in APN-KO mice compared with wild-type-mice. The ABCA1 expression in liver was also decreased in APN-KO mice. APN deficiency might cause the impaired HDL assembly by decreasing ABCA1 expression and apoA-I synthesis in the liver.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936760     DOI: 10.1016/j.febslet.2007.09.038

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  37 in total

1.  Pioglitazone-mediated changes in lipoprotein particle composition are predicted by changes in adiponectin level in type 2 diabetes.

Authors:  Susan Sam; Steven Haffner; Michael H Davidson; Ralph D'Agostino; Alfonso Perez; Theodore Mazzone
Journal:  J Clin Endocrinol Metab       Date:  2011-11-09       Impact factor: 5.958

2.  Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women.

Authors:  Tobias Pischon; Frank B Hu; Cynthia J Girman; Nader Rifai; JoAnn E Manson; Kathryn M Rexrode; Eric B Rimm
Journal:  Atherosclerosis       Date:  2011-07-20       Impact factor: 5.162

3.  Weight-Loss Diets, Adiponectin, and Changes in Cardiometabolic Risk in the 2-Year POUNDS Lost Trial.

Authors:  Wenjie Ma; Tao Huang; Yan Zheng; Molin Wang; George A Bray; Frank M Sacks; Lu Qi
Journal:  J Clin Endocrinol Metab       Date:  2016-04-07       Impact factor: 5.958

4.  ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.

Authors:  Kai Yin; Duan-fang Liao; Chao-ke Tang
Journal:  Mol Med       Date:  2010-05-12       Impact factor: 6.354

Review 5.  Mouse models of the metabolic syndrome.

Authors:  Arion J Kennedy; Kate L J Ellacott; Victoria L King; Alyssa H Hasty
Journal:  Dis Model Mech       Date:  2010 Mar-Apr       Impact factor: 5.758

6.  Lipidomic analysis of the liver identifies changes of major and minor lipid species in adiponectin deficient mice.

Authors:  Josef Wanninger; Gerhard Liebisch; Gerd Schmitz; Sabrina Bauer; Kristina Eisinger; Markus Neumeier; Noriyuki Ouchi; Kenneth Walsh; Christa Buechler
Journal:  Exp Mol Pathol       Date:  2012-03-23       Impact factor: 3.362

7.  Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism.

Authors:  Jiansheng Huang; Imene Tabbi-Anneni; Viswanath Gunda; Li Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-07       Impact factor: 4.052

8.  Endurance training enhances ABCA1 expression in rat small intestine.

Authors:  Behzad Mehdi Khabazian; Abbass Ghanbari-Niaki; Ali reza Safarzadeh-Golpordesari; Mehdi Ebrahimi; Fatemeh Rahbarizadeh; Hossein Abednazari
Journal:  Eur J Appl Physiol       Date:  2009-07-24       Impact factor: 3.078

9.  β3-Adrenoceptor activation attenuates atherosclerotic plaque formation in ApoE(-/-) mice through lowering blood lipids and glucose.

Authors:  Zhao-hong Wang; Yan-fang Li; Yan-qing Guo
Journal:  Acta Pharmacol Sin       Date:  2013-07-29       Impact factor: 6.150

10.  Serum adiponectin in relation to race-ethnicity and vascular risk factors in the Northern Manhattan Study.

Authors:  Hannah Gardener; Milita Crisby; Charlotte Sjoberg; Barry Hudson; Ronald Goldberg; Armando J Mendez; Clinton B Wright; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco
Journal:  Metab Syndr Relat Disord       Date:  2012-11-05       Impact factor: 1.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.